Aduro Biotech, Inc. ADRO
Day range unavailable
52-week range unavailable
P/E -14.2×
P/S 67.7×
P/B 17.8×
P/FCF -17.5×
EV/EBITDA -14.3×
EV/Sales 66.2×
FCF Yield -5.7%
Gross Margin 100.0%
Operating Margin -493.3%
Net Margin -477.3%
ROE -125.6%
ROIC -19.5%
ROA -28.3%
Revenue 14.4%
Operating Income 12.6%
EPS (diluted) 14.9%
Free Cash Flow 6.1%
Current Ratio 10.1×
Quick Ratio 10.1×
Debt / Equity 0.5×
Net Debt / EBITDA 0.3×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2019-12-31